📊 Score Breakdown
Offering Ability
100
Cash Runway
0
Float Risk
85
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
47%
🔄 Reverse Split
55%
• 50-day avg $0.67 below $1 exchange minimum
📉 Score Deterioration
40%
• Score rose 27 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($30M, 488% of market cap)
• Active ATM program with $30M remaining capacity
💹 Market Data
Market Cap$6.15M
Shares Outstanding5.64M
Float1.01M
Cash$508.9K
Debt$438.8K
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest58
Days to Cover1.0
% of Float0.0%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Aug 31, 2025
xbrl
XBRL CONVERTIBLE
Aug 31, 2021
8-K
8K EVENT
Apr 30, 2026
8-K
8K EVENT
Apr 20, 2026
424B3
ATM
Apr 13, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for AERA
📊 AERA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 AERA Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.